SCREENING FOR INFERTILITY


SCREENING FOR INFERTILITY  new york, we love new york

Rodinia infertility test screens for mutations associated with infertility in individuals and couples who have difficulty conceiving and maintaining a pregnancy.
Rodinia is available as a female or a male infertility panel. Each panel detects numerous infertility-causing genetic variants as well as whole, partial, or mosaic sex chromosome copy number changes.
The female infertility panel screens for 55 genes and copy number changes in the X chromosome. The male infertility panel screens for 40 genes and copy number changes in X and Y chromosomes, and Y-chromosome microdeletions.
The test offers an add-on haemophilia and thrombosis panel that checks for 21 specific genetic variants in 16 genes that are associated with recurrent pregnancy loss. 
Rodinia has been designed to identify pathogenic and likely pathogenic gene mutations with very high sensitivity and specificity. Rodinia analyzes the sequencing data produced from each sample using advanced bioinformatics which raises the sensitivity and specificity of the test. Importantly, Rodinia analyses all coding regions on the genes of interest, and therefore improves the chances of identifying pathogenic or likely pathogenic gene mutations such as single nucleotide variants, small insertions and deletions, and copy number variants. Rodinia will also report Variants of Uncertain Significance (VUS) in cases of potential pathogenicity. Infertility is considered a major disorder of the reproductive system and affects approximately 1 in 6 couples worldwide. Rodinia offers early identification of the underlying genetic cause of infertility and provides deep insight about reproductive potential and health. Early detection of mutations associated with infertility can improve prognosis and be pivotal to the choice and outcome of treatment.
The test itself is done by oral brushing collection. 
Results are reported within 2-4 weeks from sample receipt in the laboratory, so that you can make informed and early decisions on the best clinical management for your patient.
Should you want more information don't hesitate to contact DNA Consula on (+356) 7979 7910 or send an email at info@dnaconsulta.com 

< Back to Services